“…APP's biological activities including skeletal muscle hypertrophy (Mizushige et al, 2010;Kawabata et al, 2015;Watanabe et al, 2018Watanabe et al, , 2020Watanabe et al, , 2021Fujitani et al, 2019;Morisasa et al, 2019Morisasa et al, , 2022Uchida et al, 2022), anti-obesity (Oishi & Dohmoto, 2009;Mizushige et al, 2017;Maedaa et al, 2020), gut microbiota composition regulation (Hosomi et al, 2020;Maedaa et al, 2020;Tanaka et al, 2022), anti-cholesterol (Shukla et al, 2006;Hosomi et al, 2009Hosomi et al, , 2010Hosomi et al, , 2011Kato et al, 2011;Maedaa et al, 2020), blood glucose lowering (Oishi & Dohmoto, 2009;Kawabata et al, 2015;Hosomi et al, 2020) and non-alcoholic fatty liver disease (NAFLD; Shukla et al, 2006;Hosomi et al, 2009;Maedaa et al, 2020) have been reported. Although research on APP's biological activities have been conducted, there are no systematic reviews as per our knowledge.…”